A combined analysis in cases from Spain and France27 (NMO-AQP4 positive—25% vs controls—10.81%, OR = 2.74, CI 1.58–4.77, pcB ≤ 0.0008) confirmed the French results. The gene discussed is AQP4; the disease is neuromyelitis optica.